Publication: 825

Publication: 825

N047B: NCCTG phase II trial of vorinostat (suberoylanilide hydroxamic acid) in recurrent glioblastoma multiforme (GBM)

URL

Google Scholar

Citation:: J Clin Oncol vol 25 (18s) abstr 2004

Year:: 2007
Type:: Abstract
Sub type:: Poster General
Funding:: NCTN
Endpoint:: Primary
Analysis:: Primary
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:: pub

Note:

Methodological:: No
Biospecimen:: No
SDC:: No

Parents:: None
Children:: 284

Program:: OGC
Primary Committee:: Neuro-Onc
Sec. Committees:

Pharmas:
Grants:

Corr. Author:
Authors:: E. Galanis K. A. Jaeckle M. J. Maurer J. M. Reid M. M. Ames C. Giannini J. S. Hardwick D. F. Moore Jr J. A. Zwiebel J. C. Buckner

Networks:

Study: NCCTG-N047B
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:: 2

Keywords: